Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome-related lymphoma

Blood

Volumn 98, Issue 8, 2001, Pages 2358-2363

  Seneviratne, Lasika ^a   Espina, Byron M ^a   Nathwani, Bharat N ^a   Chan, Joel A ^a   Brynes, Russell K ^a   Levine, Alexandra M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; BLOOD CELL COUNT; BONE MARROW CANCER; BONE METASTASIS; CANCER SURVIVAL; CEREBROSPINAL FLUID; CLINICAL EXAMINATION; CORRELATION ANALYSIS; FEMALE; FEVER; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; HYPERHIDROSIS; IMMUNOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEPTOMENINX; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NIGHT; PATHOLOGY; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WEIGHT REDUCTION;

EID: 0035889130     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.8.2358     Document Type: Article

References (43)

1. Centers for Disease Control, Department of Health and Human Services. Revision of the case definition of acquired immunodeficiency syndrome for national reporting: United States. Ann Intern Med. 1985;103:402-403.
2. Levine AM, Meyer PR, Begandy MK, et al. Development of B-cell lymphoma in homosexual men: clinical and immunologic findings. Ann Intern Med. 1984;100:7-13.
3. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphomas in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984:311:565-570.
4. Levine AM, Gill PS, Meyer PR, et al. Retrovirus and malignant lymphoma in homosexual men. JAMA. 1985;254:1921-1925.
5. Kalter SP, Riggs SA, Cabanillas F, et al. Aggressive non-Hodgkin's lymphoma in immunocompromised homosexual males. Blood. 1985;66:655-659.
6. Lowenthal DA, Straus DJ, Campbell SW, et al. AIDS-related lymphoid neoplasia: the Memorial Hospital experience. Cancer. 1988;61:2325-2337.
7. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;108:744-753.
8. Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 1989;261:719-724.
9. Gisselbrecht C, Oksenhendler E, Tirelli U, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group. Am J Med. 1993;95:188-196.
10. Levine AM, Sullivan-Halley J, Gill PS, et al. HIV-related lymphoma: prognostic factors predictive of survival. Cancer. 1991;68:2466-2472.
11. Fisher RI, De Vita VT Jr, Johnson BL, Simon R, Young, RC. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med. 1977;63:177-182.
12. Jones SE, Rosenberg SA, Kaplan HS. Non-Hodgkin's lymphomas: bone marrow involvement. Cancer. 1972;4:954-960.
13. Coller BS, Chabner BA, Gralnick HR. Frequencies and patterns of bone marrow involvement in non-Hodgkin's lymphomas: observations on the value of bilateral biopsies. Am J Hematol. 1977;3:105-119.
14. Rasheed S, Norman GL, Gill PS, et al. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Virology. 1986;150:1-9.
15. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860-1861.
16. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer. 1974;34:1488-1503.
17. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Arlie House, Virginia, November 1997. J Clin Oncol. 1999; 17:3835-3849.
18. Scadden DT, Schenkein DP, Bernstein Z, et al. Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma. Cancer. 1998;83:2580-2587.
19. Tulpule A, Espina BM, Levine AM, et al. Treatment of AIDS-related NHL with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study [abstract 92]. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:A39.
20. Levine AM, Kaplan L, Wernz JC, et al. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA. 1991;266:84-88.
21. Levine AM, Tulpule A, Espina B, et al. Low dose methotrexate, bieomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma: effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996;78:517-526.
22. Kaplan LD, Straus DJ, Testa MA, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with HIV infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997;336:1641-1648.
23. Gill PS, Levine AM, Krailo M, et al. AIDS-related malignant lymphoma: results of prospective treat ment trials. J Clin Oncol. 1987;5:1322-1328.
24. Levine AM, Gill PS, Cohen J, et al. Suramin antiviral therapy in AIDS. Ann Intern Med. 1986;105:32-37.
25. Mehta CR, Patel NR. A network algorithm for the exact treatment of Fisher's exact test in R x C contingency tables. J Am Stat Assoc. 1983;79:427-434.
26. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
27. Tarone RE, Ware J. On distribution-free tests for equality of survival distributions. Biometrika. 1977;64:156-160.
28. Cox DR, Oakes D. Analysis of Survival Data. Lon don, United Kingdom: Methuen; 1984.
29. Bennett JM, Cain KC, Glick JH, et al. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol. 1986; 4:1462-1469.
30. Foucar K, McKenna RW, Brunning RD, et al. Bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Cancer. 1982;49:888-897.
31. Conlan MG, Bast M, Armitage JO, et al. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. J Clin Oncol. 1990;8:1163-1172.
32. Yan Y, Chan WC, Weisenburger DD, et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol. 1995; 13:1336-1342.
33. Stein RS, Ultman JE, Byrne GE, et al. Bone marrow involvement in non-Hodgkin's lymphoma: implications for staging and therapy. Cancer. 1976;37:629-636.
34. Haddy TB, Adde MA, Magrath IT. CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign? J Clin Oncol. 1991;9:1973-1982.
35. Levitt LJ, Dawson DM, Rosenthal DS, et al. CNS involvement in the non-Hodgkin's lymphomas. Cancer. 1980;45:545-552.
36. Keldensen N, Michalski W, Bentzen SM, et al. Risk factors for CNS involvement in NHL: a multivariate analysis. Acta Oncologica. 1996;35:703-708.
37. Wolf MM, Olver IN, Ding JC, et al. Non-Hodgkin's lymphoma involving the central nervous system. Aust N Z J Med. 1985; 15:16-21.
38. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8-20.
39. Hagemeister FB, Ketan R, Allen P, et al. Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. Ann Oncol. 1994;5(suppl 2):S41-S46.
40. Straus DJ, Huang J, Testa MA, et al, Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Groups protocol 142: low dose versus standard dose m-BACOD plus granulocyte-macrophage colonystimulating factor. J Clin Oncol. 1998; 16:3601-3606.
41. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993; 328:1002-1006.
42. Ratner L, Redden D, Hamzeh F, et al. Chemotherapy for HIV associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy (HAART) is not associated with excessive toxicity [abstract 92]. J AIDS. 1999;21: A32.
43. Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood. 2000;96:4084-4090.